An investigation on behalf of current long-term investors in shares of Kimberly Clark Corp (NYSE:KMB) concerning potential breaches of fiduciary duties by certain directors of Kimberly Clark Corp was announced.
Investors who are current long term investors in Kimberly Clark Corp (NYSE:KMB) shares, have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 – 1554.
The investigation by a law firm for current long term investors in NYSE:KMB stocks follows a lawsuit filed recently against Kimberly Clark over alleged securities laws violations. The investigation on behalf of current long term investors in NYSE:KMB stocks, concerns whether certain Kimberly Clark directors are liable in connection with the allegations made in that lawsuit.
Prior to October 2014, Halyard was the Health Care operating segment of Kimberly-Clark, a manufacturer of personal care, consumer tissue, and professional products. Kimberly-Clark’s common stock trades on the New York Stock Exchange under the ticker symbol “KMB.” On October 7, 2014, Kimberly-Clark announced the details for the completion of the spin-off of its Health Care segment as Halyard Health, Inc., advising its shareholders that they would receive one share of Halyard Health common stock for every eight shares of Kimberly-Clark common stock held as of the close of trading on October 23, 2014, the record date for the spin-off.
In late 2013, an outbreak of the Ebola virus began in Guinea, subsequently spreading to Liberia, Sierra Leone, and other West African nations. In August 2014, after meeting with health ministers from eleven countries, the World Health Organization designated the outbreak as a Public Health Emergency of International Concern, a rarely-used designation that invokes legal measures on disease prevention, surveillance, control, and response by 194 signatory countries. On September 30, 2014, the United States Centers for Disease Control and Prevention declared the first case of Ebola virus in the United States.
As awareness of the Ebola epidemic grew, demand surged for the personal protective equipment—i.e., eye shields, face masks and disposable gowns—made by Kimberly-Clark’s Health Care segment and subsequently by Halyard, including the Company’s MICROCOOL surgical gowns.
According to the complaint the plaintiff alleges that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Defendants made certain allegedly false and/or misleading statements and/or failed to disclose that the Company’s MICROCOOL surgical gowns consistently failed effectiveness tests and failed to meet industry standards, that Kimberly-Clark and Halyard had knowingly provided defective MICROCOOL surgical gowns to U.S. workers during the Ebola crisis, and that as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.
On May 1, 2016, 60 Minutes reported that Kimberly-Clark and Halyard had knowingly provided defective surgical gowns to U.S. workers at the height of the Ebola crisis.
On May 1, 2016, 60 Minutes reported that Kimberly Clark Corp and Halyard Health Inc had knowingly provided defective surgical gowns to U.S. workers at the height of the Ebola crisis. A Company insider claimed that Halyard Health’s MICROCOOL surgical gowns were prone to leaks and did not consistently meet the industry safety standards for the treatment of Ebola, but that Kimberly-Clark and Halyard had nonetheless “aggressively” marketed the MICROCOOL gowns to hospitals during the epidemic.
Those who purchased NYSE:KMB shares have certain options and should contact the Shareholders Foundation
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego